BIOR
Biora Therapeutics, Inc. Common Stock
BIOR
BIOR
Delisted
BIOR was delisted on the 10th of December, 2024.
30 hedge funds and large institutions have $6.46M invested in Biora Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
29% less funds holding
Funds holding: 42 → 30 (-12)
63% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 19
Holders
30
Holding in Top 10
1
Calls
$3.24M
Puts
$367K
Top Buyers
| 1 | +$144K | |
| 2 | +$71.2K | |
| 3 | +$67.1K | |
| 4 |
CF
Cantor Fitzgerald
New York
|
+$55.6K |
| 5 |
CIBC Asset Management
Toronto,
Ontario, Canada
|
+$51.2K |
Top Sellers
| 1 | -$1.1M | |
| 2 | -$209K | |
| 3 | -$88.4K | |
| 4 |
WA
WealthTrust Axiom
Wayne,
Pennsylvania
|
-$32.9K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$17.2K |